Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 20;23(19):11037.
doi: 10.3390/ijms231911037.

Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer's Disease

Quy-Susan Huynh  1   2 , Shalini Elangovan  1 , R M Damian Holsinger  1   2
Affiliations
Review

Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer's Disease

Quy-Susan Huynh et al. Int J Mol Sci. .

Abstract

Alzheimer's disease is a growing global crisis in need of urgent diagnostic and therapeutic strategies. The current treatment strategy mostly involves immunotherapeutic medications that have had little success in halting disease progress. Hypotheses for pathogenesis and development of AD have been expanded to implicate both organ systems as well as cellular reactions. Non-pharmacologic interventions ranging from minimally to deeply invasive have attempted to address these diverse contributors to AD. In this review, we aim to delineate mechanisms underlying such interventions while attempting to provide explanatory links between the observed differences in disease states and postulated metabolic or structural mechanisms of change. The techniques discussed are not an exhaustive list of non-pharmacological interventions against AD but provide a foundation to facilitate a deeper understanding of the area of study.

Keywords: deep brain stimulation; fecal microbiota transplantation; photobiomodulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Abubakar M.B., Sanusi K.O., Ugusman A., Mohamed W., Kamal H., Ibrahim N.H., Khoo C.S., Kumar J. Alzheimer’s Disease: An Update and Insights Into Pathophysiology. Front. Aging Neurosci. 2022;14:742408. doi: 10.3389/fnagi.2022.742408. - DOI - PMC - PubMed
    1. Rajmohan R., Reddy P.H. Amyloid-Beta and Phosphorylated Tau Accumulations Cause.e Abnormalities at Synapses of Alzheimer’s disease Neurons. J. Alzheimer’s Dis. JAD. 2017;57:975–999. doi: 10.3233/JAD-160612. - DOI - PMC - PubMed
    1. Tanzi R.E. The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012;2:a006296. doi: 10.1101/cshperspect.a006296. - DOI - PMC - PubMed
    1. Van Cauwenberghe C., Van Broeckhoven C., Sleegers K. The genetic landscape of Alzheimer disease: Clinical implications and perspectives. Genet. Med. 2016;18:421–430. doi: 10.1038/gim.2015.117. - DOI - PMC - PubMed
    1. Bellenguez C., Grenier-Boley B., Lambert J.C. Genetics of Alzheimer’s disease: Where we are, and where we are going. Curr. Opin. Neurobiol. 2020;61:40–48. doi: 10.1016/j.conb.2019.11.024. - DOI - PubMed